| Pronunciation: | ay za SYE ti deen |
| Brand: | Vidaza |
![]() |
Do not use this medication if you are allergic to azacitidine or mannitol, or if you have liver cancer. |
Before receiving azacitidine, tell your doctor if you are allergic to any drugs, or if you have kidney disease or liver disease.
![]() |
Do not receive this medication without telling your doctor if you are pregnant. It could cause harm to the unborn baby. Use an effective form of birth control, and tell your doctor if you become pregnant during treatment. |
If a man fathers a child while using this medication, the baby may have birth defects. Use a condom to prevent pregnancy during your treatment. Continue using condoms for at least 4 weeks after you stop using azacitidine.
Tell your caregiver right away if this medication accidentally gets on your skin. Wash the area thoroughly with soap and warm water.
![]() |
Do not receive a "live" vaccine while you are being treated with azacitidine, and avoid coming into contact with anyone who has recently received a live vaccine. There is a chance that the virus could be passed on to you. |
Azacitidine can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Your kidney or liver function may also need to be tested. Do not miss any scheduled visits to your doctor. Do not miss any scheduled visits to your doctor.
Azacitidine is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body.
Azacitidine is used to treat certain types of bone marrow cancers and blood cell disorders.
Azacitidine may also be used for other purposes not listed in this medication guide.
![]() |
You should not be given this medication if you are allergic to azacitidine or mannitol, or if you have advanced liver cancer. |
If you have certain conditions, you may need a dose adjustment or special tests to safely receive this medication. Before you receive azacitidine, tell your doctor if you are allergic to any drugs, or if you have:
![]() |
FDA pregnancy category D. This medication can cause harm to an unborn baby. Do not receive azacitidine without telling your doctor if you are pregnant. Use an effective form of birth control, and tell your doctor if you become pregnant during treatment. |
If a man fathers a child while using this medication, the baby may have birth defects. Use a condom to prevent pregnancy during your treatment. Continue using condoms for at least 4 weeks after you stop using azacitidine.
![]() |
It is not known whether azacitidine passes into breast milk, but it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby. You may need to either stop nursing or stop receiving azacitidine. |
Azacitidine is given as an injection through a needle placed into a vein, or as a shot given under the skin. Your doctor, nurse, or other healthcare provider will give you this injection in a clinic or hospital setting.
Azacitidine must be given slowly through an IV infusion, and can take up to 40 minutes to complete. If you are receiving a shot under your skin, you may require two injections to complete your dose.
You may also be given medications to reduce nausea and vomiting while you are receiving azacitidine.
![]() |
This medication is usually given for 7 days in a row every 4 weeks for at least 4 treatment cycles. Your treatment schedule may be different. Follow your doctor's instructions. |
Tell your caregiver right away if this medication accidentally gets on your skin. Wash the area thoroughly with soap and warm water.
Azacitidine can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Your kidney or liver function may also need to be tested. Do not miss any scheduled visits to your doctor.
Contact your doctor if you miss an appointment for your azacitidine injection.
![]() |
Seek emergency medical attention if you think you have received too much of this medicine. |
Overdose can cause diarrhea, nausea, and vomiting.
Avoid being near people who have colds, the flu, or other contagious illnesses. Contact your doctor at once if you develop signs of infection.
Avoid getting any of this medicine on your skin. If this does happen, tell your caregiver right away and wash the area with soap and warm water.
![]() |
Do not receive a "live" vaccine while you are being treated with azacitidine, and avoid coming into contact with anyone who has recently received a live vaccine. There is a chance that the virus could be passed on to you. |
![]() |
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. |
![]() |
Call your doctor at once if you have any of these serious side effects: |
Less serious side effects may include:
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
There may be other drugs that can interact with azacitidine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
Your doctor or pharmacist can provide more information about azacitidine.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 4.03. Revision date: 12/15/2010.
Your use of the content provided in this service indicates that you have read, understood and agree to the End-User License Agreement, which can be accessed by clicking on this link.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT @sanfordtimg: #sanfordresearch's Dr. Amy Elliott is filling @keloland in on the CRCAIH Annual Summit http://t.co/brWO1zbKUd